6 Countries Approve Cancer Treatment...FDA to Follow?

This situation is developing quickly across the globe...

A brand-new “cancer vaccine” is entering hospitals in Germany, England, and four countries in East Asia.

It’s already sailed through two clinical trials... and it’s set to finish the third by April 30.

On that day, a critical FDA announcement could put this vaccine into the hands of 14 million cancer sufferers worldwide.

Six other governments have already approved this cancer vaccine.

And all indicators – from what's been seen in clinical trial results, to formal discussions in the oncologist community – point to one conclusion: The FDA is about to follow in their footsteps.

The agency has even “tipped its hand” by passing a rare legal ruling to move this cutting-edge treatment quickly through trials.

For investors in this company before this April 30th announcement, respected biotechnology investor Dr. Joe Duarte expects gains of 2,700% or more in the near future.

Dr. Duarte recently explained his step-by-step rationale for investing in this company, as well as everything you need to know about this amazing development, in a presentation he just released to the public.

To view it, click here now.

To receive the full presentation, and register for ongoing updates on this story and other emerging investing opportunities, enter your email address below.